Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.
scientific article published on 19 October 2014
Author/s
author: Laura Pina-Camacho, David Fraguas, Celso Arango, Iluminada Corripio, Eva Grasa, Roberto Rodríguez-Jiménez, Marina Mitjans, Julio Bobes, Barbara Arias, Pilar Saiz Coria, Covadonga M. Díaz-Caneja, Miryam Fernández Hernandez, Julio Sanjuán
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.